Genetic Study Reveals Why Obesity Drugs Work Better for Some People
Scientists have identified genetic variants that explain why popular obesity drugs like Ozempic and Wegovy work better for some people than others. A study analyzing data from almost 28,000 people who used 23andMe DNA tests found specific genetic markers that predict both drug effectiveness and side effects. The research focused on GLP-1 medications, which have become increasingly popular for weight loss but show varying results across patients. Some people lose significant weight on these drugs while others see minimal benefits or experience severe gastrointestinal side effects. The genetic variants discovered could help doctors personalize treatment plans, identifying which patients are most likely to benefit from these medications and which might be at higher risk for adverse reactions. This represents a step toward precision medicine in obesity treatment, potentially improving outcomes while reducing unnecessary side effects. The findings could also help pharmaceutical companies develop more targeted approaches to weight management medications in the future.
Key facts
- Study analyzed data from almost 28,000 people who used 23andMe DNA tests
- Research identified genetic variants affecting both drug effectiveness and gastrointestinal side effects
Where sources agree
- Genetic variants influence response to GLP-1 obesity medications
- The study analyzed data from nearly 28,000 people
Where sources differ
- No political disagreements evident from single scientific source
How different outlets framed it
Left-leaning coverage: Information not available from the single source provided - this appears to be a scientific study report rather than politically-framed coverage.
Right-leaning coverage: Information not available from the single source provided - this appears to be a scientific study report rather than politically-framed coverage.
Limits of this briefing
Analysis based on only one source from a scientific journal, lacking diverse political perspectives that would typically inform triangulation analysis.